| |
| |
|
| Insider
Information: |
O'connor Daniel |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
730,449 |
|
|
Indirect Shares
|
42,005 |
|
|
| Direct
Value |
$76,085 |
|
|
|
Indirect Value
|
$25,518 |
|
|
| Total
Shares |
772,454 |
|
|
| Total
Value |
$101,603 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 16.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Advaxis Inc |
ADXS |
Chief Executive Office... |
2017-06-30 |
618,352 |
|
0 |
Premium* |
|
|
Oncosec Medical Incorporation |
ONCS |
CEO and President, Dir... |
2021-04-30 |
96,097 |
2018-02-05 |
0 |
Premium* |
|
|
Zyversa Therapeutics Ord Shs |
ZVSA |
Chief Executive Office... |
2022-01-06 |
0 |
2022-01-06 |
42,005 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
Director |
2022-06-01 |
16,000 |
2022-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2022-06-01 |
4 |
B |
$0.61 |
$9,789 |
D/D |
16,000 |
16,000 |
2.39 |
% |
|
| ZVSA |
Zyversa Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
I/I |
42,005 |
42,005 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2021-04-30 |
4 |
S |
$4.86 |
$15,416 |
D/D |
(3,172) |
96,097 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2021-02-01 |
4 |
S |
$7.71 |
$26,314 |
D/D |
(3,413) |
99,269 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2020-11-02 |
4 |
S |
$3.79 |
$12,431 |
D/D |
(3,280) |
102,682 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2020-07-31 |
4 |
S |
$4.20 |
$13,159 |
D/D |
(3,133) |
105,962 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2020-05-29 |
4 |
D |
$2.23 |
$99,170 |
D/D |
(44,471) |
109,095 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
90,580 |
153,566 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2020-04-30 |
4 |
S |
$1.79 |
$5,504 |
D/D |
(3,075) |
62,986 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2020-01-31 |
4 |
S |
$1.96 |
$5,202 |
D/D |
(2,654) |
66,061 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2019-10-31 |
4 |
S |
$2.16 |
$4,596 |
D/D |
(2,128) |
68,715 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2019-07-31 |
4 |
D |
$2.23 |
$4,808 |
D/D |
(2,156) |
70,843 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2019-04-30 |
4 |
D |
$0.57 |
$12,067 |
D/D |
(21,357) |
729,992 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2019-01-31 |
4 |
D |
$0.88 |
$22,280 |
D/D |
(25,318) |
751,349 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO and President |
• • – |
2018-12-24 |
4 |
A |
$0.00 |
$0 |
D/D |
750,000 |
776,667 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO & President |
• • – |
2018-11-07 |
4 |
B |
$0.91 |
$9,100 |
D/D |
10,000 |
26,667 |
2.81 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
CEO |
• • – |
2018-02-05 |
4 |
B |
$1.50 |
$25,001 |
D/D |
16,667 |
16,667 |
2.81 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-06-30 |
4 |
A |
$6.49 |
$4,816 |
D/D |
742 |
618,352 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
177,102 |
617,610 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-05-31 |
4 |
A |
$8.07 |
$3,397 |
D/D |
421 |
440,508 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
142,996 |
440,087 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-04-28 |
4 |
A |
$8.56 |
$2,987 |
D/D |
349 |
297,091 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-03-31 |
4 |
A |
$8.17 |
$2,982 |
D/D |
365 |
296,742 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-02-28 |
4 |
D |
$8.79 |
$914 |
D/D |
(104) |
296,377 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Executive Officer |
• • – |
2017-02-28 |
4 |
A |
$8.79 |
$4,307 |
D/D |
490 |
296,481 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
